Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028.
Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of the body. They can be produced by the cancer cell itself or by other tissues in the body in response to cancer. Some common forms of cancer include breast, prostate, cervical, lung, and colorectal cancer. They are widely used for diagnosing the disease, monitoring their progression, distinguishing between invasive and non-invasive tumors, predicting the chances of recurrences and recording therapeutic treatment efficacy. Enzymes, proteins, nucleic acids, genes, specific cells. and peptides are some of the common types of biomarkers. As a result, they are widely used as prognostics, surrogate endpoints, diagnostics, and personalized medicines.
Cancer Biomarkers Market Trends:
The increasing prevalence of cancer across the globe is creating a positive outlook for the market. Biomarkers are widely used for early cancer detection and during treatment and management to accurately and reliably predict outcomes. In line with this, the increasing incidences of lung cancer due to the upsurge in pollution levels, smoking trends and poor ingestion habits is augmenting the market growth. Moreover, various technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and the artificial inelegance (AI) that assist in predicting the recurrence of cancer after treatment, are providing an impetus to the market growth. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early diagnosis and the significant shift toward personalized medicine for cancer treatment due to the lack of standard diagnosis is favoring the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities and the implementation of various government initiatives for enhancing the drug development processes, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application and end user.
Breakup by Profiling Technology:
Omic Technologies
Imaging Technologies
Immunoassays
Cytogenetics
Breakup by Biomolecule:
Genetic Biomarkers
Protein Biomarkers
Glyco-Biomarkers
Breakup by Cancer Type:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others
Breakup by Application:
Diagnostics
Prognostics
Risk Assessment
Drug Discovery and Development
Others
Breakup by End User:
Hospitals
Academic and Research Institutions
Ambulatory Surgical Centers
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMйrieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global cancer biomarkers market in 2022?
2. What is the expected growth rate of the global cancer biomarkers market during 2023-2028?
3. What are the key factors driving the global cancer biomarkers market?
4. What has been the impact of COVID-19 on the global cancer biomarkers market?
5. What is the breakup of the global cancer biomarkers market based on the biomolecule?
6. What is the breakup of the global cancer biomarkers market based on the cancer type?
7. What are the key regions in the global cancer biomarkers market?
8. Who are the key players/companies in the global cancer biomarkers market?
The global cancer biomarkers market size reached US$ 24.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028.
Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of the body. They can be produced by the cancer cell itself or by other tissues in the body in response to cancer. Some common forms of cancer include breast, prostate, cervical, lung, and colorectal cancer. They are widely used for diagnosing the disease, monitoring their progression, distinguishing between invasive and non-invasive tumors, predicting the chances of recurrences and recording therapeutic treatment efficacy. Enzymes, proteins, nucleic acids, genes, specific cells. and peptides are some of the common types of biomarkers. As a result, they are widely used as prognostics, surrogate endpoints, diagnostics, and personalized medicines.
Cancer Biomarkers Market Trends:
The increasing prevalence of cancer across the globe is creating a positive outlook for the market. Biomarkers are widely used for early cancer detection and during treatment and management to accurately and reliably predict outcomes. In line with this, the increasing incidences of lung cancer due to the upsurge in pollution levels, smoking trends and poor ingestion habits is augmenting the market growth. Moreover, various technological advancements in genetic biomarker discovery, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), gene expression profiling (microarray), and the artificial inelegance (AI) that assist in predicting the recurrence of cancer after treatment, are providing an impetus to the market growth. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early diagnosis and the significant shift toward personalized medicine for cancer treatment due to the lack of standard diagnosis is favoring the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities and the implementation of various government initiatives for enhancing the drug development processes, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on profiling technology, biomolecule, cancer type, application and end user.
Breakup by Profiling Technology:
Omic Technologies
Imaging Technologies
Immunoassays
Cytogenetics
Breakup by Biomolecule:
Genetic Biomarkers
Protein Biomarkers
Glyco-Biomarkers
Breakup by Cancer Type:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others
Breakup by Application:
Diagnostics
Prognostics
Risk Assessment
Drug Discovery and Development
Others
Breakup by End User:
Hospitals
Academic and Research Institutions
Ambulatory Surgical Centers
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, bioMйrieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Illumina Inc., Qiagen N.V., Sino Biological Inc. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global cancer biomarkers market in 2022?
2. What is the expected growth rate of the global cancer biomarkers market during 2023-2028?
3. What are the key factors driving the global cancer biomarkers market?
4. What has been the impact of COVID-19 on the global cancer biomarkers market?
5. What is the breakup of the global cancer biomarkers market based on the biomolecule?
6. What is the breakup of the global cancer biomarkers market based on the cancer type?
7. What are the key regions in the global cancer biomarkers market?
8. Who are the key players/companies in the global cancer biomarkers market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANCER BIOMARKERS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PROFILING TECHNOLOGY
6.1 Omic Technologies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Imaging Technologies
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunoassays
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytogenetics
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY BIOMOLECULE
7.1 Genetic Biomarkers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Protein Biomarkers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Glyco-Biomarkers
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY CANCER TYPE
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Stomach Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Prognostics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Risk Assessment
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Drug Discovery and Development
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 MARKET BREAKUP BY END USER
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Academic and Research Institutions
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Ambulatory Surgical Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Diagnostic Laboratories
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 MARKET BREAKUP BY REGION
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT ANALYSIS
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 VALUE CHAIN ANALYSIS
14 PORTERS FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Agilent Technologies Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 bioMйrieux SA
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Danaher Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffmann-La Roche AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 General Electric Company
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Illumina Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Qiagen N.V.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sino Biological Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CANCER BIOMARKERS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PROFILING TECHNOLOGY
6.1 Omic Technologies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Imaging Technologies
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Immunoassays
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cytogenetics
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY BIOMOLECULE
7.1 Genetic Biomarkers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Protein Biomarkers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Glyco-Biomarkers
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY CANCER TYPE
8.1 Breast Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Lung Cancer
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Colorectal Cancer
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Prostate Cancer
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Stomach Cancer
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Prognostics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Risk Assessment
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Drug Discovery and Development
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 MARKET BREAKUP BY END USER
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Academic and Research Institutions
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Ambulatory Surgical Centers
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Diagnostic Laboratories
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 MARKET BREAKUP BY REGION
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT ANALYSIS
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 VALUE CHAIN ANALYSIS
14 PORTERS FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Agilent Technologies Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Becton Dickinson and Company
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 bioMйrieux SA
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Danaher Corporation
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 F. Hoffmann-La Roche AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 SWOT Analysis
16.3.7 General Electric Company
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Illumina Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Qiagen N.V.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Sino Biological Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2023-2028
Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2023-2028
Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Cancer Biomarkers Market: Competitive Structure
Table 9: Global: Cancer Biomarkers Market: Key Players
Table 1: Global: Cancer Biomarkers Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Cancer Biomarkers Market Forecast: Breakup by Profiling Technology (in Million US$), 2023-2028
Table 3: Global: Cancer Biomarkers Market Forecast: Breakup by Biomolecule (in Million US$), 2023-2028
Table 4: Global: Cancer Biomarkers Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
Table 5: Global: Cancer Biomarkers Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Cancer Biomarkers Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Cancer Biomarkers Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Cancer Biomarkers Market: Competitive Structure
Table 9: Global: Cancer Biomarkers Market: Key Players
LIST OF FIGURES
Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2022
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2022
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2022
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2022
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2022
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2022
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2022
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis
Figure 1: Global: Cancer Biomarkers Market: Major Drivers and Challenges
Figure 2: Global: Cancer Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Cancer Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Cancer Biomarkers Market: Breakup by Profiling Technology (in %), 2022
Figure 5: Global: Cancer Biomarkers Market: Breakup by Biomolecule (in %), 2022
Figure 6: Global: Cancer Biomarkers Market: Breakup by Cancer Type (in %), 2022
Figure 7: Global: Cancer Biomarkers Market: Breakup by Application (in %), 2022
Figure 8: Global: Cancer Biomarkers Market: Breakup by End User (in %), 2022
Figure 9: Global: Cancer Biomarkers Market: Breakup by Region (in %), 2022
Figure 10: Global: Cancer Biomarkers (Omic Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Cancer Biomarkers (Omic Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Cancer Biomarkers (Imaging Technologies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Cancer Biomarkers (Imaging Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Cancer Biomarkers (Immunoassays) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Cancer Biomarkers (Immunoassays) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Cancer Biomarkers (Cytogenetics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Cancer Biomarkers (Cytogenetics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Cancer Biomarkers (Genetic Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Cancer Biomarkers (Genetic Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Cancer Biomarkers (Protein Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Cancer Biomarkers (Protein Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Cancer Biomarkers (Glyco-Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Cancer Biomarkers (Glyco-Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Cancer Biomarkers (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Cancer Biomarkers (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Cancer Biomarkers (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Cancer Biomarkers (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Cancer Biomarkers (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Cancer Biomarkers (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Cancer Biomarkers (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Cancer Biomarkers (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Cancer Biomarkers (Stomach Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Cancer Biomarkers (Stomach Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Cancer Biomarkers (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Cancer Biomarkers (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Cancer Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Cancer Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Cancer Biomarkers (Prognostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Cancer Biomarkers (Prognostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Cancer Biomarkers (Risk Assessment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Cancer Biomarkers (Risk Assessment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Cancer Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Cancer Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Cancer Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Cancer Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Cancer Biomarkers (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Cancer Biomarkers (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Cancer Biomarkers (Academic and Research Institutions) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Cancer Biomarkers (Academic and Research Institutions) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Global: Cancer Biomarkers (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Global: Cancer Biomarkers (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Global: Cancer Biomarkers (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Global: Cancer Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Global: Cancer Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: North America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: North America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United States: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United States: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Canada: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Canada: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Asia-Pacific: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Asia-Pacific: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: China: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: China: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Japan: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Japan: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: India: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: India: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: South Korea: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: South Korea: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Australia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Australia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Indonesia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Indonesia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Europe: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Europe: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Germany: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Germany: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: France: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: France: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: United Kingdom: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: United Kingdom: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Italy: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Italy: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Spain: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Spain: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Russia: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Russia: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Latin America: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Latin America: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Brazil: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Brazil: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Mexico: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 99: Mexico: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 100: Others: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 101: Others: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 102: Middle East and Africa: Cancer Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 103: Middle East and Africa: Cancer Biomarkers Market: Breakup by Country (in %), 2022
Figure 104: Middle East and Africa: Cancer Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 105: Global: Cancer Biomarkers Industry: SWOT Analysis
Figure 106: Global: Cancer Biomarkers Industry: Value Chain Analysis
Figure 107: Global: Cancer Biomarkers Industry: Porter's Five Forces Analysis
